APPLICATION
ANDA076830
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-31
LATEST ACTION
2020-07-15
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
OFLOXACINDiscontinued
OFLOXACIN 0.3% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2020-07-15Labeling · Supplement 8 · standardAP
2009-02-13Labeling · Supplement 5AP
2004-08-31OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.